Reckitt Benckiser Group’s stock price target has edged slightly higher, with consensus analyst estimates rising from £59.74 to £60.33. This modest adjustment suggests a cautiously optimistic view as analysts respond to changing market dynamics and company performance. Read on for insights into how analysts’ evolving perspectives are shaping the outlook for Reckitt Benckiser, and how you can follow these developments in the future.

Recent analyst commentary on Reckitt Benckiser Group showcases a spectrum of perspectives, with some experts expressing increasing confidence in the company’s performance, while others maintain a more cautious view given sector and valuation pressures. The following highlights summarize the latest bullish and bearish takeaways emerging from analyst research:

???? Bullish Takeaways

Several analysts, including recent updates from Barclays, have increased their price targets for Reckitt Benckiser. Barclays raised its target from £62 to £65 as of October 8, 2025, citing improved earnings visibility and execution momentum.

There is broad recognition of the company’s successful cost control and transparent strategy, contributing to expectations of steady top-line expansion and improved profitability.

Bulls emphasize Reckitt Benckiser’s resilience in defensive categories, with persistent consumer demand and effective management reinforcing the company’s attractive risk profile.

While many see upside potential, even the most optimistic analysts acknowledge that near-term risks and demanding valuations require consistent operational delivery to justify further gains.

???? Bearish Takeaways

Other analysts, such as Morgan Stanley, have tempered their outlook by lowering price targets while maintaining Hold ratings. A notable revision was made from £59 to £57 in late September 2025, reflecting concerns over persistent market share challenges.

Skeptics highlight sensitivity around the current valuation, suggesting that a significant portion of anticipated growth may already be reflected in the share price.

Bears cite headwinds in capturing incremental market share and toughening competition, which could dampen short- to medium-term performance expectations.

Reservations persist, especially regarding Reckitt Benckiser’s ability to translate strategic initiatives into accelerated growth without sacrificing margins in a competitive landscape.

Together, these viewpoints underscore the market’s close watch on Reckitt Benckiser Group’s execution and future trajectory, with both optimism and caution shaping the stock’s evolving narrative.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

The Board of Directors has approved a new share buyback plan, authorizing Reckitt Benckiser Group to repurchase its own shares in the open market.

The company has launched a substantial share repurchase program and is committing up to £1,000 million to buy back and cancel shares over the next year.

Reckitt Benckiser Group has provided an upgraded outlook for 2025, with Core Reckitt targeting like-for-like net revenue growth above 4 percent. The Group expects total growth of 3 percent to 4 percent for the year.

An interim 2025 dividend of 84.4 pence per share has been recommended, which represents an increase from the previous year, with payment planned for September 2025.

Consensus Analyst Price Target has risen slightly from £59.74 to £60.33. This reflects a modest increase in fair value estimation.

Discount Rate remains effectively unchanged at 6.82 percent, which indicates stable underlying risk assumptions.

Revenue Growth expectations have increased modestly from 3.13 percent to 3.21 percent.

Net Profit Margin shows a minor decrease, shifting from 17.12 percent to 17.11 percent.

Future P/E ratio has increased from 17.22x to 18.37x. This suggests a higher valuation relative to anticipated earnings.

Narratives are an innovative way to invest, combining a company’s story with tangible financial forecasts and a fair value estimate. On Simply Wall St’s Community page, millions of investors use Narratives to connect the numbers to real-world events, making it easier to spot when to buy or sell as fair value and price change. Narratives update dynamically and immediately reflect news or results, offering you a smarter, more dynamic investment decision tool.

Read the original Narrative on Reckitt Benckiser Group to keep up with:

How emerging market growth in India and China is set to drive revenue and margin expansion, supporting above-market returns.

The company’s strategy around cost reduction, brand investment, and portfolio optimization to power sustained earnings growth.

The risks, such as legal challenges and fierce competition, that could impact future profits and what to watch as the story unfolds.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include RKT.L.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com